TCMBANKIN000266 |
2,3-seco-3-oxoolean-12-en-2-oicacid |
|
C30H48O3 |
|
CC1(CCC2(CCC3(C(=CCC4C3(CCC(C4(C)CC(=O)O)C(C)(C)C=O)C)C2C1)C)C)C |
TCMBANKIN001245 |
5-hydroxyflavone |
|
C15H10O3 |
238.24 g/mol |
C1=CC=C(C=C1)C2=CC(=O)C3=C(C=CC=C3O2)O |
TCMBANKIN001937 |
Gentisein |
NSC 329491; ACM529497; 9H-Xanthen-9-one, 1,3,7-trihydroxy-; BDBM50155446; gentisein; 1,3,7-Trihydroxy-xanthen-9-one; ZINC6094144; 1,3,7-Trihydroxy-9H-xanthen-9-one, 9CI; CHEBI:5323; BRN 0384687; AKOS022662257; MolPort-022-397-026; 1,3,7-trihydroxyxanthen-9-one; C10065; AIDS-122703; 1,3,7-trihydroxy-9-xanthenone; Xanthen-9-one, 1,3,7-trihydroxy-; Gentisein(NSC 329491); 529-49-7; CHEMBL361025; AK199105; DTXSID20200944; AC1NQYS4; LS-162507; CCRIS 4008; NSC329491; 1,3,7-trihydroxy-9H-xanthen-9-one; 1,3,7-Trihydroxyxanthone; AIDS122703; SCHEMBL2315926; XANTHONE DERIV; NSC-329491 |
C13H8O5 |
244.2 |
C1=CC2=C(C=C1O)C(=O)C3=C(C=C(C=C3O2)O)O |
TCMBANKIN008824 |
2,3-seco-3-oxours-12-en-2-oicacid |
|
C30H48O3 |
|
CC1CCC2(CCC3(C(=CCC4C3(CCC(C4(C)CC(=O)O)C(C)(C)C=O)C)C2C1C)C)C |
TCMBANKIN012319 |
3-3''linked-(2'-hydroxy-4-hydroxychalcone)-(2'''-hydroxy-4 ''-hydroxy dihydrochalcone) |
|
C30H24O6 |
|
C1=CC=C(C(=C1)C(=O)CCC2=CC(=C(C=C2)O)C3=C(C=CC(=C3)C=CC(=O)C4=CC=CC=C4O)O)O |
TCMBANKIN029881 |
methoxy-3-(1,1'-dimethylallyl)-6a,10a-dihydro-benzo(1,2-c)chroman-6-one |
|
C19H20O3 |
|
CC(=CCC1=C2C(=C3C(=C1)C=CC(=O)O3)C=CC(O2)(C)C)C |
TCMBANKIN033439 |
Amarogentin |
amarogentin |
C29H30O13 |
586.54 |
C=CC1C2CCOC(=O)C2=COC1OC3C(C(C(C(O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O |
TCMBANKIN035447 |
isogentisin |
|
C14H10O5 |
258.23 g/mol |
COC1=CC2=C(C=C1)OC3=CC(=CC(=C3C2=O)O)O |
TCMBANKIN036814 |
β-Amyrin |
SCHEMBL14226156; beta-Amyrine; β- amyrin; beta-amyrin ; beta-amyrin; 12-oleanex-3beta-ol; NSC-527971 |
|
426.72 |
|
TCMBANKIN038707 |
alpha-amyrin |
α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 |
C30H50O |
426.72 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
TCMBANKIN039851 |
3-3''linked-(2'-hydroxy-4-o-isoprenylchalcone)-(2'''-hydroxy-4''-o-isoprenyl dihydrochalcone) |
|
C40H40O6 |
|
|
TCMBANKIN042126 |
Uvaol 3-O-palmitate |
|
|
|
|
TCMBANKIN043196 |
9(11),12-ursadien-3β-ol 3-o-palmitate |
|
C46H78O2 |
|
CCCCCCCCCCCCCCCC(=O)OC1CCC2(C(C1(C)C)CCC3(C2=CC=C4C3(CCC5(C4C(C(CC5)C)C)C)C)C)C |
TCMBANKIN043781 |
Geraldone |
|
C16H12O5 |
284.263 |
c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(OC([H])([H])[H])c2[H])=C([H])C3=O)c3c([H])c1[H] |
TCMBANKIN046131 |
Betulin 3-O-palmitate |
|
|
|
|
TCMBANKIN046432 |
Gentiopicroside tetraacetate |
(5R-trans)-5,6-Dihydro-6-((2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy)-5-vinyl-1H,3H-pyrano(3,4-c)pyran-1-one; EINECS 234-250-9; [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-[(4-ethenyl-8-oxo-4,6-dihydro-3H-pyrano[3,4-c]pyran-3-yl)oxy]oxan-2-yl]methyl acetate; AC1L3FBL; 11019-08-2; gentiopicroside tetraacetate |
C24H28O13 |
524.5 g/mol |
C1([H])([H])OC(=O)C(=C([H])O[C@@]([H])(O[C@@]2([H])[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])[C@]([H])(OC(=O)C([H])([H])[H])[C@@]([H])(C([H])([H])OC(=O)C([H])([H])[H])O2)[C@]3(C([
H])=C([H])[H])[H])C3=C1[H] |
TCMBANKIN047539 |
Erythrodiol 3-O-palmitate |
|
|
681.1 g/mol |
|
TCMBANKIN058032 |
gertiopicrin |
gentiopicroside; 4-ethenyl-3-methyl-4,6-dihydro-3H-pyrano[3,4-c]pyran-8-one; 6-(hydroxymethyl)oxane-2,3,4,5-tetrol; A814958; MEGxp0_000872; (5R,6S)-5-ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; Gentiopicroside; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; EINECS 244-070-2; NSC-606402; LMPR01020110; C09782; ZINC04098340; 20831-76-9; (5R,6S)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; NSC606402; gentiopicrin; ACon1_001284; (5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-5-vinyl-5,6-dihydro-3H-pyrano[5,4-c]pyran-1-one; 1H,3H-Pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-D-glucopyranosyloxy)-5,6-dihydro-, (5R-trans)-; (5R-trans)-6-(beta-D-Glucopyranosyloxy)-5,6-dihydro-5-vinyl-1H,3H-pyrano(3,4-c)pyran-1-one |
C16H20O9 |
356.32 |
C=CC1C(OC=C2C1=CCOC2=O)OC3C(C(C(C(O3)CO)O)O)O |
TCMBANKIN058171 |
GENOP |
BRN 2209119; NCIOpen2_000913; BSPBio_003051; Gentisinic acid polymer; BENZOIC ACID,2,5-DIHYDROXY; AIDS-002955; Salicylic acid, 5-hydroxy-; Spectrum4_001821; 4955-90-2 (SODIUM SALT); KBio1_000538; C00628; KBio2_001721; 5-Hydroxysalicylic acid; Resorcyllic acid, alphaodium 2,5-dihydroxybenzoate; SPBio_000846; KBioSS_001721; Spectrum2_000773; Kyselina gentisinova [Czech]; 39319_FLUKA; 2,5-Dioxybenzoic acid; 2,5-Dhba; Gensigen; 490-79-9; KBioGR_002487; KBio3_002271; 4-10-00-01441 (Beilstein Handbook Reference); Spectrum3_001326; Benzoic acid, 2,5-dihydroxy-; Acidum gentisicum [INN-Latin]; Gentisate; Acido gentisico [INN-Spanish]; Spectrum5_000581; Gentisinic acid; Spectrum_001241; 2,5-Dihydroxybenzoic acid; Kyselina 2,5-dihydroxybenzoova [Czech]; IVK/9045696; NSC27224; KBio2_004289; Acide gentisique [INN-French]; Gentisic acid; DivK1c_000538; NSC8512 (SODIUM SALT); AIDS027706; NSC 27224; AIDS-027706; Gensigon; EINECS 207-718-5; Hydroquinonecarboxylic acid; CHEBI:17189; AI3-60431; WLN: QVR BQ EQ; 149357_ALDRICH; IDI1_000538; AIDS002955; Acido 2,5-diidrossibenzoico [Italian]; Oprea1_039290; NINDS_000538; InChI=1/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11; KBio2_006857; NSC49098; 2,5-dihydroxy benzoic acid; 2,5-dihydroxybenzoic acid; 2,5-dihydroxy-benzoic acid; gentisicacid; 2, 5-dihydroxybenzoic acid; gentisic acid |
C7H6O4 |
154.12g/mol |
C1=CC(=C(C=C1O)C(=O)O)O |
TCMBANKIN058704 |
lupeol |
AC-1371; AKOS015960466; SCHEMBL14067725; 4CN-0933; C08628; BC201808; Lup-20(29)-en-3.beta.-ol; NSC90487; ZINC04081455; D0RA6H; Lupeol; LMPR01060013; lupeol ; Monogynol B; .beta.-Viscol; NCI60_042005; lup-20(29)-en-3beta-ol; Lupenol |
C30H50O |
426.7 g/mol |
CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
TCMBANKIN060544 |
alpha-amyrin |
|
C30H50O |
426.72 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
TCMBANKIN061734 |
Gentisin |
C10066; 1,7-dihydroxy-3-methoxy-xanthen-9-one; 1,7-Dihydroxy-3-methoxyxanthen-9-one; 1,7-Dihydroxy-3-methoxyxanthone; gentisin; Gentisine; AIDS351438; AIDS-351438; 1,7-dihydroxy-3-methoxy-9-xanthenone; BRN 0384788; 437-50-3; Xanthen-9-one, 1,7-dihydroxy-3-methoxy-; CCRIS 3151; Gentianin; 9H-Xanthen-9-one, 1,7-dihydroxy-3-methoxy-; 1,7-dihydroxy-3-methoxy-xanthone; EINECS 207-114-1; GENTIANIC ACID; 5-18-04-00497 (Beilstein Handbook Reference); |
C14H10O5 |
258.23 g/mol |
COC1=CC(=C2C(=C1)OC3=C(C2=O)C=C(C=C3)O)O |
TCMBANKIN061767 |
Isogingerenone-B |
(E)-1-(4-hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)hept-4-en-3-one; isogingerenone-b; (E)-1-(4-hydroxy-3,5-dimethoxy-phenyl)-7-(4-hydroxy-3-methoxy-phenyl)hept-4-en-3-one;isogingerenone b |
C22H26O6 |
386.44g/mol |
COC1=CC(=CC(=C1O)OC)CCC(=O)C=CCCC2=CC(=C(C=C2)O)OC |